Last month, we were pleased to announce to our readership that Current Oncology’s 2011 Impact Factor increased to 2.473! This was a significant increa

Last month, we were pleased to announce to our readership that Current Oncology’s 2011 Impact Factor increased to 2.473! This was a significant increase from our 2010 stats, where we received our first impact factor of 1.820. We couldn’t have achieved this without the valuable contribution of Editors, Section Editors, Reviewers, and Authors.

We would like to take this opportunity to invite you to contribute to the future growth of the journal by:

Submitting your manuscript to Current Oncology - we encourage submissions from all fields of cancer medicine. Click here for information about article submission.
Becoming a reviewer for Current Oncology - as a reviewer you will be asked to read and critique articles. Reviewers play an integral part in ensuring that the high standard of Current Oncology is met and that the articles published are of interest to the oncology community. Please take a moment to register on our website.

We would also like to take the opportunity to invite you to recommend information to include in our newsletter. We welcome information that is of importance to the Oncology community such as events, oncology conferences, important publications and clinical trials. Please send any recommendations to current_oncology@multi-med.com.

Multimed-clean

Multimed Inc
Publisher of Current Oncology
***
InPress-CON

Volume 19, Number 4 (August 2012)

The latest issue of Current Oncology is now available online. Please visit the following link to view full text articles from Volume 19, Number 4 (August 2012):
http://www.current-oncology.com/index.php/oncology/issue/current/showToc

Volume 19, Supplement 2 (Oncology in China)

We recently published selected manuscripts that were submitted for a Scholars’ Forum & Workshop, held in Guangzhou, China. The papers were published in a special supplemental issue titled “Oncology in China.” Please visit the following link to view full text articles from this special issue:
http://www.current-oncology.com/index.php/oncology/issue/view/76

***
LookingAhead-CON

Upcoming in Current Oncology

The future table of contents for Current Oncology, Volume 19, Number 5 (October 2012) is now available. For the most up-to-date listing of scheduled papers, please visit the following link:
http://www.current-oncology.com/index.php/oncology/about/futureTOC

Watch for the upcoming Supplement in 2012!

Prostate Cancer: A Canadian Perspective

Guest Editor, Dr. Fred Saad, is the guest editor of an upcoming supplement to Current Oncology dedicated to prostate cancer. This supplement will cover many of the issues that physicians face on a daily basis when dealing with this disease. Dr. Saad is gathering some of the most respected Canadian authorities to tackle the myriad of important topics that will make up this supplement.

***
***
ReadersChoice-COn

Have you had the chance to view these Current Oncology “Most-Read” articles?

Most Read Articles in PubMed Central (July 2012)

A primer of bone metastases management in breast cancer patients
Petrut B, Trinkaus M, Simmons C, Clemons M
Curr Oncol. 2008 Jan;15(Suppl 1):S50-7

Management of skin rash during EGFR-targeted monoclonal antibody treatment for gastrointestinal malignancies: Canadian recommendations
Melosky B, Burkes R, Rayson D, Alcindor T, Shear N, Lacouture M
Curr Oncol. 2009 Jan;16(1):16-26

Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: a consensus statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea
J.A. Maroun, L.B. Anthony, N. Blais, R. Burkes, S.D. Dowden, G. Dranitsaris, B. Samson, A. Shah, M.P. Thirlwell, M.D. Vincent, R. Wong
Curr Oncol. 2007 Feb; 14(1):13-20

Most Read Recently* Published Articles at www.current-oncology.com

A comprehensive bone-health management approach for men with prostate cancer receiving androgen deprivation therapy
Lee CE, Leslie WD, Czaykowski P, Gingerich J, Geirnaert M, Lau YK
Curr Oncol. 2011 Aug;18(4):e163-72

Emerging trends in the treatment of triple-negative breast cancer in Canada: a survey
Verma S, Provencher L, Dent R.
Curr Oncol. 2011 Aug;18(4):180-90

Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma
Sherman M, Burak K, Maroun J, Metrakos P, Knox JJ, Myers RP, Guindi M, Porter G, Kachura JR, Rasuli P, Gill S, Ghali P, Chaudhury P, Siddiqui J, Valenti D, Weiss A, Wong R
Curr Oncol. 2011 Oct; 18(5): 228–240

*Published within past 12 months

***
HaveYouHeard-CON

Current Oncology Welcomes New Members to our Editorial Team

We are pleased to welcome our newest section editors to our editorial team:

Dr. Matt Mumber, Harbin Clinic, USA (Section Editor, Integrative Oncology)
Dr. Jean-Pierre M. Ayoub, Centre Hospitalier de l'Université de Montréal, Montreal, QC (Section Editor, Medical Oncology)

***

2nd Annual Best of Oncology 2012 Conference

November 30, 2012 - Toronto, ON, Westin Prince Hotel
February 22, 2013 – Vancouver BC, TBD

The focus of this meeting is to provide medical oncologists and other oncology practitioners with a summary of the most significant treatment advances over the course of the year.

This meeting is a full-day event with presentations focused on key disease sites.

Meeting Objectives:

To discuss the pivotal oncology trials and research presented in the different disease sites;
To review the current standard of care for key malignancies;
To discuss the current controversies in the management of specific cancers.

Join the Toronto meeting, organized in collaboration with the COMET group, and participate in sessions led by Dr. Mark Clemons, Dr. Natasha Leighl, Dr. Helen Mackay, Dr. Sebastien Hotte and more!

The meeting is accredited for 6.5 CME credits.

Register now! Early bird rates expire September 30th!

Join Canadian Oncology Pharmacists at NOPS 2012 in Saskatoon, October 25 to 28, 2012

NOPS 2012 Header

Register now to participate in the National Oncology Pharmacy Symposium (NOPS 2012), a leading edge educational event produced by the Canadian Association of Pharmacy in Oncology (CAPhO) that defines the practice of oncology pharmacy in Canada. NOPS 2012 will be held October 25 to 28, 2012 at the Sheraton Cavalier Saskatoon. This year’s theme is ‘Patients First’, which reflects the oncology pharmacist’s responsibility of providing patient-centered care.

If you are an oncology pharmacist, technician, pharmacy assistant and other health care professional interested in the practice of oncology pharmacy in Canada, register today to attend NOPS 2012 and become a member of CAPhO. Also sign up to receive the e-newsletter so that you stay informed.

***
QuickLinks-CON
***

Contact Us

Address-CON
 
Email-CON
 
Phone-CON
 
Web-CON
email facebook twitter
1px